Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in ...

By Ernie Mundell HealthDay ReporterTHURSDAY, July 31, 2025 (HealthDay News) — There’s potentially exciting news from a trial ...

The results suggest the possibility of a vaccine for HIV/AIDS, which killed more than half a million people last year.

Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...

Plasma samples showed an association between suppressed extracellular vesicles and an increased risk for liver cancer.

Receiving treatment within the first month of life could protect children for at least three years, a study suggests.

Previous research has shown that HIV-specific CD8 T-cell responses directed against five genetically conserved HIV-1 protein ...

We may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause ...

HIV antivirals may be the key to stopping HTLV-1, a deadly virus with no cure. In a decade-long study, researchers ...

A new study in Nature shows that delivering a single injection of gene therapy at birth may offer years-long protection ...

A new study in Nature shows that delivering a single injection of gene therapy at birth may offer years-long protection ...

Scientists reported administering an HIV gene therapy once to primates of different ages through simple injections into ...